Literature DB >> 27908503

Cobalt-60 Machines and Medical Linear Accelerators: Competing Technologies for External Beam Radiotherapy.

B J Healy1, D van der Merwe2, K E Christaki3, A Meghzifene3.   

Abstract

Medical linear accelerators (linacs) and cobalt-60 machines are both mature technologies for external beam radiotherapy. A comparison is made between these two technologies in terms of infrastructure and maintenance, dosimetry, shielding requirements, staffing, costs, security, patient throughput and clinical use. Infrastructure and maintenance are more demanding for linacs due to the complex electric componentry. In dosimetry, a higher beam energy, modulated dose rate and smaller focal spot size mean that it is easier to create an optimised treatment with a linac for conformal dose coverage of the tumour while sparing healthy organs at risk. In shielding, the requirements for a concrete bunker are similar for cobalt-60 machines and linacs but extra shielding and protection from neutrons are required for linacs. Staffing levels can be higher for linacs and more staff training is required for linacs. Life cycle costs are higher for linacs, especially multi-energy linacs. Security is more complex for cobalt-60 machines because of the high activity radioactive source. Patient throughput can be affected by source decay for cobalt-60 machines but poor maintenance and breakdowns can severely affect patient throughput for linacs. In clinical use, more complex treatment techniques are easier to achieve with linacs, and the availability of electron beams on high-energy linacs can be useful for certain treatments. In summary, there is no simple answer to the question of the choice of either cobalt-60 machines or linacs for radiotherapy in low- and middle-income countries. In fact a radiotherapy department with a combination of technologies, including orthovoltage X-ray units, may be an option. Local needs, conditions and resources will have to be factored into any decision on technology taking into account the characteristics of both forms of teletherapy, with the primary goal being the sustainability of the radiotherapy service over the useful lifetime of the equipment.
Copyright © 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cobalt-60 teletherapy; external beam radiotherapy; medical linear accelerator

Mesh:

Substances:

Year:  2016        PMID: 27908503     DOI: 10.1016/j.clon.2016.11.002

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  9 in total

Review 1.  Cancer control in the Pacific: big challenges facing small island states.

Authors:  Diana Sarfati; Rachel Dyer; Filipina Amosa-Lei Sam; Michael Barton; Freddie Bray; Eka Buadromo; Alec Ekeroma; Sunia Foliaki; James Fong; Josephine Herman; Linda Huggins; Kiki Maoate; Ineke Meredith; Glen Mola; Neal Palafox; Viliami Puloka; Hai-Rim Shin; Jane Skeen; Wendy Snowdon; Malama Tafuna'i; Andrea Teng; David Watters; Paula Vivili
Journal:  Lancet Oncol       Date:  2019-08-05       Impact factor: 41.316

2.  Dose Estimation Curves Following In Vitro X-ray Irradiation Using Blood From Four Healthy Korean Individuals.

Authors:  Mi Ae Jang; Eun Ae Han; Jin Kyung Lee; Kwang Hwan Cho; Hee Bong Shin; You Kyoung Lee
Journal:  Ann Lab Med       Date:  2019-01       Impact factor: 3.464

3.  Radiotherapy treatment in cancer control and its important role in Africa.

Authors:  Ntokozo Ndlovu
Journal:  Ecancermedicalscience       Date:  2019-07-25

4.  Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo.

Authors:  Yuki Shibata; Hironobu Yasui; Kei Higashikawa; Naoki Miyamoto; Yuji Kuge
Journal:  PLoS One       Date:  2019-12-04       Impact factor: 3.240

5.  A closer look at the efficiency calibration of LaBr3(Ce) and NaI(Tl) scintillation detectors using MCNPX for various types of nuclear investigations.

Authors:  Ghada ALMisned; Hesham M H Zakaly; Fatema T Ali; Shams A M Issa; Antoaneta Ene; Gokhan Kilic; V Ivanov; H O Tekin
Journal:  Heliyon       Date:  2022-10-01

6.  Mobilising stakeholders to improve access to state-of-the-art radiotherapy in low- and middle-income countries.

Authors:  Ndimofor Chofor; Pierre Bopda; Rebecca Bücker; Azeh Ivo; Ernest Okonkwo; Kra Joel; Zanzem Tung; Taofeeq Ige; Holger Wirtz; Wilfred Ngwa
Journal:  Ecancermedicalscience       Date:  2021-05-10

Review 7.  Evidence-based improvisation: Facing the challenges of cervical cancer care in Uganda.

Authors:  Megan Swanson; Stefanie Ueda; Lee-May Chen; Megan J Huchko; Carol Nakisige; Jane Namugga
Journal:  Gynecol Oncol Rep       Date:  2018-01-05

8.  Overcoming Challenges in Providing Radiation Therapy to Patients With Cancer in Nigeria and Experience in the National Hospital Abuja, Nigeria.

Authors:  Simeon Chinedu Aruah; Obinna Chizoba Asogwa; Fatima I Ubah; Nandul Nimark Maurice; Rasaaq Oyesegun; Taofeeq A Ige; C Norman Coleman; Manjit Dosanjh; David Pistenmaa
Journal:  JCO Glob Oncol       Date:  2020-08

9.  Definitive Radiation Treatment Patterns and Outcomes for Low and Intermediate Risk Prostate Cancer Patients: A Cross-Continental Comparative Study.

Authors:  Francis A Asamoah; Joel Yarney; Shivanshu Awasthi; Verna Vanderpuye; Mary A Dadzie; Angelina Fink; Arash O Naghavi; Afua Abrahams; James E Mensah; Evans Sasu; Samuel N Tagoe; Jasreman Dhillon; Peter A S Johnstone; Kosj Yamoah
Journal:  Am J Clin Oncol       Date:  2019-12       Impact factor: 2.339

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.